Cruz is retiring from MMA - his final fight a loss to Marlon "Chito" Vera in August 2022 in his home state of California.
UFC legend Dominick Cruz retires as ‘complicated’ injury derails final fight - The former bantamweight champion was due to ...
Two-time UFC bantamweight champion Dominick Cruz has retired from mixed martial arts at age 39 after a training injury forced ...
The former UFC men's bantamweight champion announced his retirement from MMA competition in a social-media post on Thursday.
Dominick Cruz is calling it a career. After an injury forced him out of UFC Fight Night 252, Cruz (24-4 MMA, 7-3 UFC) ...
14h
Hosted on MSNFormer WEC, UFC Bantamweight Champ Dominick Cruz Retires From MMAOne of the greatest Ultimate Fighting Championship fighters in the history of the sport is deciding to hang up his gloves. Ex-UFC and World Extreme Cagefighting bantamweight kingpin Dominick Cruz ...
14h
MMA Weekly on MSNFormer two-time UFC champion announces retirementFormer two-time bantamweight champion Dominick Cruz expected to fight one more time and had booked his retirement fight. Cruz ...
15h
Hosted on MSNFollowing UFC Seattle withdrawal, Dominick Cruz officially announces his retirementUFC Seattle in a few weeks was supposed to be the final fight for former bantamweight champion Dominick Cruz (24-4).
Dominick Cruz, among the greatest bantamweight fighters in MMA history, announced Thursday that he is retiring from the sport ...
The former UFC men's bantamweight champion announced his retirement from MMA competition in a social-media post on Thursday.
16h
Hosted on MSNDominick Cruz announces retirement after withdrawing from UFC Seattle: ‘Sometimes the body just doesn’t cooperate’Dominick Cruz is hanging up his gloves. Cruz was expected to return to action after over two years out of the cage with a fight scheduled against Rob Font later this month at UFC Seattle; however, the ...
Atara, Pierre Fabre hit a hurdle with Ebvallo in the US courtesy of manufacturing plant's shortfalls
Then in 2023, Pierre Fabre took on the drug's U.S. rights in a deal worth up to $640 million. Related In deal worth up to $640M, Pierre Fabre doubles down on its T-cell partnership with Atara ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results